Subsequent pregnancy outcome after first pregnancy with normotensive early-onset intrauterine growth restriction at <34 weeks of gestation

Hypertension in Pregnancy

Volumn 30, Issue 1, 2011, Pages 37-44

  Evers, Annemieke C ^a   Van Rijn, Bas B ^a   Van Rossum, Maartje M ^a   Bruinse, Hein W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Early onset IUGR; Maternal and fetal outcome; Normotensive; Subsequent pregnancy

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DELIVERY; FEMALE; FETUS OUTCOME; FOLLOW UP; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL HYPERTENSION; NETHERLANDS; NEWBORN DISEASE; OUTCOME ASSESSMENT; PERINATAL DEATH; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURITY; PRIMIGRAVIDA; RETROSPECTIVE STUDY; SOLUTIO PLACENTAE; TERTIARY HEALTH CARE;

ADULT; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 79952951307     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641955.2010.484080     Document Type: Article

References (22)

1. Clausson B, Cnattingius S, Axelsson O. Preterm and term births of small for gestational age infants: A population-based study of risk factors among nulliparous women. Br J Obstet Gynaecol 1998; 105:1011-1017. (Pubitemid 28442328)
2. McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999; 340:1234-1238. (Pubitemid 29181643)
3. Kramer MS, Olivier M, McLean FH, Willis DM, Usher RH. Impact of intrauterine growth retardation and body proportionality on fetal and neonatal outcome. Pediatrics 1990; 86:707-713. (Pubitemid 20379399)
4. Pallotto EK, Kilbride HW. Perinatal outcome and later implications of intrauterine growth restriction. Clin Obstet Gynecol 2006; 49:257-269. (Pubitemid 44317914)
5. Gardosi J, Mul T, Mongelli M, Fagan D. Analysis of birthweight and gestational age in antepartum stillbirths. Br J Obstet Gynaecol 1998; 105:524-530. (Pubitemid 28261383)
6. Zaw W, Gagnon R, da Silva O. The risks of adverse neonatal outcome among preterm small for gestational age infants according to neonatal versus fetal growth standards. Pediatrics 2003; 111:1273-1277. (Pubitemid 36682259)
7. Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 2000; 182:198-206. (Pubitemid 30074392)
8. Xiong X, Demianczuk NN, Saunders LD, Wang FL, Fraser WD. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol 2002; 155:203-209. (Pubitemid 34117298)
9. Piper JM, Langer O, Xenakis EM, McFarland M, Elliott BD, Berkus MD. Perinatal outcome in growth-restricted fetuses: Do hypertensive and normotensive pregnancies differ? Obstet Gynecol 1996; 88:194-199. (Pubitemid 26250290)
10. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Preeclampsia and fetal growth. Obstet Gynecol 2000; 96:950-955.
11. Torrance HL, Mulder EJ, Brouwers HA, van Bel F, Visser GH. Respiratory outcome in preterm small for gestational age fetuses with or without abnormal umbilical artery Doppler and/or maternal hypertension. J Matern Fetal Neonatal Med 2007; 20:613-621. (Pubitemid 47221561)
12. Kloosterman GJ. Intrauterine growth and intrauterine growth curves. Ned Tijdschr Verloskd Gynaecol 1969; 69:349-365.
13. van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 2006; 195:723-728. (Pubitemid 44292141)
14. Berghella V. Prevention of recurrent fetal growth restriction. Obstet Gynecol 2007; 110:904-912. (Pubitemid 47508758)
15. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003; 41:437-445. (Pubitemid 36314613)
16. van Runnard Heimel PJ, Huisjes AJ, Franx A, Koopman C, Bots ML, Bruinse HW. A randomised placebo-controlled trial of prolonged prednisolone administration to patients with HELLP syndrome remote from term. Eur J Obstet Gynecol Reprod Biol 2006; 128:187-193. (Pubitemid 44311330)
17. Ananth CV, Peltier MR, Chavez MR, Kirby RS, Getahun D, Vintzileos AM. Recurrence of ischemic placental disease. Obstet Gynecol 2007; 110:128-133. (Pubitemid 47015711)
18. Visser GH, Huisman A, Saathof PW, Sinnige HA. Early fetal growth retardation: Obstetric background and recurrence rate. Obstet Gynecol 1986; 67:40-43. (Pubitemid 16174296)
19. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006; 195:40-49. (Pubitemid 43927490)
20. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing preeclampsia and its complications. Cochrane Database Syst Rev 2007; CD004659.
21. Leitich H, Egarter C, Husslein P, Kaider A, Schemper M. A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol 1997; 104:450-459. (Pubitemid 27189685)
22. Toal M, Keating S, Machin G, et al. Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images. Am J Obstet Gynecol 2008; 198:330.e1-7.